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SUMMARY. In the present study, the bark ethanol extract of Maytenus guyanensis Klotzch (Celastraceae)
was investigated for total phenol content, free radical scavenging (DPPH,ABTS, superoxide anion radical
and singlet oxygen), antiinflammatory, antiplatelet and antiaggregating activities. M. guyanensis exhibited
IC50 8.2 ± 0.2, 28.4 ± 0.7, 35.6 ± 3.0 and 517 ± 70.8 μg/mL in the DPPH, ABTS, superoxide and singlet oxy-
gen assays, respectively. Total phenol content was found to be 58.7 ± 1.7 mEq gallic acid (mg/g dry ex-
tract). Significant antiinflammatory activity was demonstrated when extract was orally administrated (400
mg/kg b.w.) reducing edema in 40 % when compared with carrageenin. Also, exhibited antiplatelet aggre-
gating activity, with IC50 142 ± 14.3, 133 ± 2.3 and 166 ± 0.3 μg/mL, for platelet aggregation, when induced
by adrenalin, adenosine diphosphate or arachidonic acid, respectively. These results suggest that M. guya-
nensis bark extract could have potential applications in oxidative, inflammatory and homeostasis-related
dysfunctions.
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